Rui Ma

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

UV Filters with Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay

Rui Ma · Toxicological Sciences · 2003 · 199 citations · Full text

Comparative characterization of mesenchymal stem cells from human dental pulp and adipose tissue for bone regeneration potential

Qiaoqiao Jin, Keyong Yuan, Wen-Zhen Lin et al. · Artificial Cells Nanomedicine and Biotechnology · 2019 · 177 citations · Full text

Tissue Engineering, Engineering, Bone Tissue Engineering +24

The decapeptide CMS001 enhances swimming endurance in mice

Huali Zhang, Rong Lu, Yanjiao Zhou et al. · Peptides · 2008 · 129 citations

Physiological Research, Molecular Neuroscience, Molecular Physiology +5